Immunopanning selection of A2B5-positive cells increased the differentiation efficiency of induced pluripotent stem cells into oligodendrocytes

Neuroscience Letters

Volumn 489, Issue 2, 2011, Pages 79-83

  Ogawa, Shin ichiro ^a   Tokumoto, Yasuhito ^a   Miyake, Jun ^a   Nagamune, Teruyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

A2B5 antibody; Immunopanning; Induced pluripotent stem cell; Multiple sclerosis; Oligodendrocyte; Regenerative medicine

Indexed keywords

MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINEAGE; CELL SELECTION; CONTROLLED STUDY; IMMUNOPANNING; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; INDUCED PLURIPOTENT STEM CELLS; MICE; MYELIN BASIC PROTEINS; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; TRANSCRIPTION FACTORS;

EID: 78651419739     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.11.070     Document Type: Article

References (25)

1. Abney E.R., Williams B.P., Raff M.C. Tracing the development of oligodendrocytes from precursor cells using monoclonal antibodies, fluorescence-activated cell sorting, and cell culture. Dev. Biol. 1983, 100:166-171.
2. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., Raff M.C. Cell death and control of cell survival in oligodendrocyte lineage. Cell 1992, 70:31-46.
3. Billon N., Jolicoeur C., Ying Q.L., Smith A., Raff M. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J. Cell Sci. 2002, 115:3657-3665.
4. Cizkova D., Cizek M., Nagyova M., Novotna L., Jergova S., Radonak J., Hlucilova J., Vanicky I. Enrichment of rat oligodendrocyte progenitor cells by magnetic cell sorting. J. Neurosci. Method 2009, 184:88-94.
5. Eisenbrath G.S., Walsh F.S., Nirenberg M. Monoclonal antibody to plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:4913-4917.
6. Fanarraga M.L., Sommer I., Griffiths I.R. O-2A progenitors of mouse optic nerve exhibit a developmental pattern of antigen expression different from the rat. Glia 1995, 15:95-104.
7. Franklin R.J., Ffench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
8. Kang S.-M., Cho M.S., Seo H., Yoon C.J., Oh S.K., Choi Y.M., Kim D.-W. Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 2007, 25:419-424.
9. Magoski N.S., Walz W., Juurlink B.H.J. Identification of mouse type-2-like astrocytes: demonstration of glutamate and GABA transmitter active responses. J. Neurosci. Res. 1992, 33:91-102.
10. Matthieu J.M., Tosci M., Gardinier M.V. Abnormal regulation of the myelin basic protein gene during development of myelin-deficient mouse. Ann. NY Acad. Sci. 1990, 605:240-247.
11. Miura K., Okada Y., Aoi T., Okada A., Takahashi K., Okita K., Nakagawa M., Koyanagi M., Tanabe K., Ohnuki M., Ogawa D., Ikeda E., Okano H., Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotech. 2009, 27:743-745.
12. Mujtaba T., Piper D.R., Kalyani A., Groves A.K., Lucero M.T., Rao M.S. Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev. Biol. 1999, 214:113-127.
13. Nistor G.I., Totoiu M.O., Haque N., Carpenter M.K., Keirstead H.S. Human embryonic stem cells differentiated into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005, 49:385-396.
14. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
15. Pfeiffer S.E., Warrington A.E., Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol. 1993, 3:191-197.
16. Ranscht B., Clapahaw P.A., Price J., Noble M., Seifert W. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:2709-2713.
17. Saito M., Kitamura H., Sugiyama K. The specificity of monoclonal antibody A2B5 to c-series gangliosides. J. Neurochem. 2001, 78:64-74.
18. Saito M., Sugiyama K. Expression of c-series gangliosides in rat hepatocytes and liver tissues. Biochem. Biophys. Acta 1999, 1472:617-624.
19. Sher F., Balasubramaniyan V., Boddeke E., Copray S. Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy. Curr. Opin. Neurol. 2008, 21:607-614.
20. Sommer I., Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nerve system. Dev. Biol. 1981, 83:311-327.
21. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
22. Tokumoto Y., Ogawa S., Nagamune T., Miyake J. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pulipotent stem cells versus embryonic stem cells in vitro. J. Biosci. Bioeng. 2010, 109:622-628.
23. Watkins T.A., Emery B., Mulinyawe S., Barres B.A. Distinct stages of myelination regulated by γ-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 2008, 60:555-569.
24. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
25. Yamanaka Y. A fresh look at iPS cells. Cell 2009, 137:13-17.